vyne stock forecast zacks

VYNE might move higher on growing optimism about its earnings prospects which is reflected by its upgrade to a Zacks Rank 2 Buy. View VYNE Therapeutics Inc VYNE investment stock information.

Mnlo Twitter Search Twitter

VYNE stock price quote with breaking news financials statistics charts and more.

. Stock Price Forecast According to 11 stock analysts the average 12-month stock price forecast for VYNE stock is 479 which predicts an increase of 183457. PSRU a media conglomerate focused on the energizing of entertainment in. Zacks Investment Research is releasing its prediction for VYNE based on the 1-3 month trading system that more than doubles the SP 500.

VYNE Therapeutics VYNE Delayed Data from NSDQ 022 USD 000 -175 Updated Nov 17 2022 0353 PM ET After-Market. Their VYNE share price forecasts range from 150 to 150. In the short term.

VYNE Therapeutics VYNE Delayed Data from NSDQ 022 USD 000 -175 Updated Nov 17 2022 0353 PM ET After-Market. 023 001 240 758 PM ET Add to. 023 001 240 758 PM ET Add to portfolio Zacks.

Their QDEL share price forecasts range from 8600 to 13000. Analyst making an incorrect forecast. According to analysts consensus price target of 150 VYNE Therapeutics has a forecasted upside of 5443 from its current price of 023.

VYNE stock forecast Our latest prediction for VYNE Therapeutics Incs stock price was made on the Aug. Zacks Investment Research upgraded shares of VYNE Therapeutics NASDAQVYNE from a sell rating to a hold rating in a report published on Thursday morning. VYNE Stock Price Prediction 150 54433 Upside Based on 1 Wall Street analysts offering 12 month price targets for VYNE Therapeutics in the last 3 months.

16 2021 when the stock price was at 178. Los Angeles California Nov. Zacks Investment Research upgraded.

The average price target is. According to 1 Wall Street analyst that have issued a 1 year VYNE price target the average VYNE price target is 150 with the highest VYNE stock price forecast at 150 and the. Amount of Analyst Coverage.

Zacks Investment Research upgraded. 4 equities research analysts have issued 12 month price targets for QuidelOrthos stock. Get a real-time VYNE Therapeutics Inc.

VYNE VYNE or the Company a biopharmaceutical company developing proprietary. 21 2022 GLOBE NEWSWIRE -- Valiant Eagle Inc. Find real-time VYNE - Vyne Therapeutics Inc stock quotes company profile news and forecasts from CNN Business.

See reviews photos directions phone numbers and more for Zacks locations in Los Angeles CA. 12 2022 GLOBE NEWSWIRE -- VYNE Therapeutics Inc.

Vyne Therapeutics Inc Vyne Stock Price Quote News Stock Analysis